UK markets closed

CellaVision AB (publ) (0MR5.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
369.00+10.58 (+2.95%)
At close: 05:30PM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 3N/A
S&P500 52-week change 326.14%
52-week high 3368.50
52-week low 3368.50
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 819.71M
% held by insiders 117.35%
% held by institutions 165.30%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.25
Trailing annual dividend yield 30.63%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 19.94%
Operating margin (ttm)22.83%

Management effectiveness

Return on assets (ttm)12.08%
Return on equity (ttm)19.85%

Income statement

Revenue (ttm)708.28M
Revenue per share (ttm)29.69
Quarterly revenue growth (yoy)22.30%
Gross profit (ttm)N/A
EBITDA 202.18M
Net income avi to common (ttm)141.22M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)56.80%

Balance sheet

Total cash (mrq)166.98M
Total cash per share (mrq)7
Total debt (mrq)56.09M
Total debt/equity (mrq)7.39%
Current ratio (mrq)3.22
Book value per share (mrq)31.81

Cash flow statement

Operating cash flow (ttm)249.2M
Levered free cash flow (ttm)128.84M